COVID-19: Vaccines and Therapeutics
Leaders from Chicago-based Esperanza Health Centers, a federally qualified health center, discuss their work to keep the city’s Southwest Side community healthy throughout the COVID-19 pandemic.
Today’s podcast features how Esperanza Health Centers - a federally qualified health center in Chicago – has worked to keep their community healthy throughout the pandemic. It is moderated by AHA’s Julia Resnick, senior program manager for strategic initiatives. She is joined by Esperanza’s CEO,…
New research by the National Institutes of Health has confirmed the safety of blood donation and transfusions from COVID-19. NIH concluded that transfusions’ likelihood of infection transmission is a little over 1 in 100,000, or 0.001%.
Moderna yesterday announced an agreement to use Thermo Fisher Scientific to increase the scale of its COVID-19 vaccine finish/fill sterile manufacturing. The deal will enable production to begin in the third quarter of 2021.
The National Institutes of Health yesterday announced the start of a phase 1/2 clinical trial to investigate the safety and immunogenicity of mixed boosted COVID-19 vaccination regimens.
President Biden today announced a national month of action to mobilize the nation to get vaccinated against COVID-19 before the Fourth of July. The White House’s goal is to get 70% of U.S. adults vaccinated with at least one shot by July Fourth.
Responding to the Pandemic: Information, Care Expertise and Vaccines. Maintaining and Expanding Access. Fueling Innovation. Coordinating Care to Meet People Where They Are.
Moderna asked the Food and Drug Administration to grant full approval of its COVID-19 vaccine for people age 18 years and older.
A new study published in the New England Journal of Medicine is confirming Pfizer’s claims of the high levels of effectiveness among adolescents of its COVID-19 vaccine.
The Centers for Disease Control and Prevention recommended clinicians report all cases of inflammation of the heart muscle (myocarditis) or lining (pericarditis) after COVID-19 vaccination to the Vaccine Adverse Event Reporting System, citing an increase since April in cases reported after…